RU2005117843A - METHOD FOR PREVENTION OF TRANSPLANT REFUSION AFTER THROUGH KERATOPLASTY IN CHILDREN IN THE RISK GROUP - Google Patents

METHOD FOR PREVENTION OF TRANSPLANT REFUSION AFTER THROUGH KERATOPLASTY IN CHILDREN IN THE RISK GROUP Download PDF

Info

Publication number
RU2005117843A
RU2005117843A RU2005117843/14A RU2005117843A RU2005117843A RU 2005117843 A RU2005117843 A RU 2005117843A RU 2005117843/14 A RU2005117843/14 A RU 2005117843/14A RU 2005117843 A RU2005117843 A RU 2005117843A RU 2005117843 A RU2005117843 A RU 2005117843A
Authority
RU
Russia
Prior art keywords
children
prevention
keratoplasty
transplant
refusion
Prior art date
Application number
RU2005117843/14A
Other languages
Russian (ru)
Other versions
RU2297227C2 (en
Inventor
Алла В чеславовна Плескова (RU)
Алла Вячеславовна Плескова
Александра Васильевна Хватова (RU)
Александра Васильевна Хватова
Original Assignee
Московский научно-исследовательский институт глазных болезней им. Гельмгольца (RU)
Московский научно-исследовательский институт глазных болезней им. Гельмгольца
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Московский научно-исследовательский институт глазных болезней им. Гельмгольца (RU), Московский научно-исследовательский институт глазных болезней им. Гельмгольца filed Critical Московский научно-исследовательский институт глазных болезней им. Гельмгольца (RU)
Priority to RU2005117843/14A priority Critical patent/RU2297227C2/en
Publication of RU2005117843A publication Critical patent/RU2005117843A/en
Application granted granted Critical
Publication of RU2297227C2 publication Critical patent/RU2297227C2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Claims (1)

Способ профилактики отторжения трансплантата после сквозной кератопластики у детей в группе высокого риска, включающий системное введение циклоспорина и метипреда, отличающийся тем, что циклоспорин в разовой дозе 2 мг/кг веса и метипред - 0,5 мк/кг веса вводят перорально один раз в сутки с первого послеоперационного дня в течение 6-12 месяцев.A method for the prevention of transplant rejection after end-to-end keratoplasty in children at high risk, including systemic administration of cyclosporine and metipred, characterized in that cyclosporin in a single dose of 2 mg / kg of weight and metipred is 0.5 μ / kg of weight is administered orally once a day from the first postoperative day for 6-12 months.
RU2005117843/14A 2005-06-09 2005-06-09 Method for preventing transplants's detachment after through keratoplasty in children in the group of risk RU2297227C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2005117843/14A RU2297227C2 (en) 2005-06-09 2005-06-09 Method for preventing transplants's detachment after through keratoplasty in children in the group of risk

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2005117843/14A RU2297227C2 (en) 2005-06-09 2005-06-09 Method for preventing transplants's detachment after through keratoplasty in children in the group of risk

Publications (2)

Publication Number Publication Date
RU2005117843A true RU2005117843A (en) 2006-12-20
RU2297227C2 RU2297227C2 (en) 2007-04-20

Family

ID=37666525

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2005117843/14A RU2297227C2 (en) 2005-06-09 2005-06-09 Method for preventing transplants's detachment after through keratoplasty in children in the group of risk

Country Status (1)

Country Link
RU (1) RU2297227C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2770287C1 (en) * 2021-08-12 2022-04-15 федеральное государственное автономное учреждение "Национальный медицинский исследовательский центр "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации Method for the treatment and prevention of corneal transplant rejection

Also Published As

Publication number Publication date
RU2297227C2 (en) 2007-04-20

Similar Documents

Publication Publication Date Title
Nair et al. Sirolimus monotherapy in nephrotoxicity due to calcineurin inhibitors in liver transplant recipients
WO2003013609A1 (en) Sustained-release medicines
TW200640487A (en) Combination of XOLAIR with immunosuppressive agent
WO2007009806A3 (en) Solid dosage formulations of narcotic drugs having improved buccal adsorption
WO2006116148A3 (en) (7-arlysubstituted 2, 3-dihydr0-1-benz0furan-2-yl) alkylamines in the treatment' of substance abuse
WO2005069933A3 (en) Methods of treating an inflammatory-related disease
JP2008543936A5 (en)
Pescovitz et al. Sirolimus and mycophenolate mofetil for calcineurin-free immunosuppression in renal transplant recipients
WO2008013630A3 (en) Calcium aluminosilicate pharmaceutical
EP2402003A3 (en) Diclofenac formulations and methods of use
WO2006050002A3 (en) Compositions for controlled delivery of pharmaceutically active compounds
RU2007132971A (en) METHODS AND MATERIALS WITH TRANS-CLOMIPHENES FOR TREATMENT OF MEN'S INFERTILITY
EP2060255A3 (en) Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection
RU2005117843A (en) METHOD FOR PREVENTION OF TRANSPLANT REFUSION AFTER THROUGH KERATOPLASTY IN CHILDREN IN THE RISK GROUP
RU2006146326A (en) METHOD FOR TREATING CHRONIC VIRAL HEPATITIS C
MX2007002291A (en) Perorally administrable antimicrobial composition.
van Mourik et al. Immunosuppressive drugs in paediatric liver transplantation
WO2004096125A3 (en) Pharmaceutical compositions releasing their active agents from a buccal or sublingual location to overcome an absorption window problem
JP2006527741A5 (en)
Kyriakides et al. Use of cyclosporine in renal transplantation
RU2003108477A (en) METHOD FOR SIMULATING SEPTIC SHOCK AND POLYORGANIC DEFICIENCY IN SMALL LABORATORY ANIMALS
EP0943339A3 (en) Method of preventing allograft rejection
Shah et al. Therapeutic drug monitoring of sirolimus
Diekmann et al. Sirolimus dosage during and after conversion from calcineurin inhibitor therapy to sirolimus in chronic kidney transplant patients
JP2006503049A5 (en)

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20070610